For Companies and Institutions
Key Links
For Institutional Investors
Putting our long-tenured investment teams on the line to earn the trust of institutional investors.
Direct access to market leading liquidity harnessed through world-class research, tools, data, and analytics.
Helping institutional investors, traditional and alternative asset and fund managers, broker dealers and equity issuers meet the demands of a rapidly evolving market.
Leveraging cutting-edge technology and innovative tools to bring clients industry-leading analysis and investment advice.
Helping hedge funds, asset managers and institutional investors meet the demands of a rapidly evolving market.
Global short-term fixed income strategies designed to help clients manage liquidity through the cycle.
Key Links
For Individuals
For Employers
Enhance your equity compensation offering with solutions designed to empower your employees and bring your reward strategy to life.
Key Links
Who We Serve
Key Links
Explore a variety of insights.
Key Links
Insights by Topic
Explore a variety of insights organized by different topics.
Key Links
Insights by Type
Explore a variety of insights organized by different types of content and media.
Key Links
We aim to be the most respected financial services firm in the world, serving corporations and individuals in more than 100 countries.
Key Links
Learn more about how J.P. Morgan utilizes Cleareye’s ClearTrade platform to help future-proof the challenges faced by trade finance operations today.
| 00:02:51
J.P. Morgan has strategically aligned and invested in Cleareye.ai to help digitize and "future-proof" trade finance operations.
| 00:02:51
J.P. Morgan has strategically aligned and invested in Cleareye.ai to help digitize and "future-proof" trade finance operations.
(SPEECH)
[00:00:00.00] [MUSIC PLAYING]
[00:00:01.82] How do you future-proof trade finance operations? At J.P. Morgan Payments, we believe it's leading by example and embracing industry changes. And it all begins with redefining the way trade finance operations are run. With over 28 billion physical trade documents circulated and manually reviewed each year, there is significant room to improve process efficacy.
[00:00:24.86] The human eye is subject to error, exposing financial institutions to potential regulatory and reputational risk. And with an ever-changing regulatory landscape combined with the costs and resource implications of manual trade document review processes, the time for change is now.
[00:00:42.23] J.P. Morgan Payments quickly recognized the urgent need to digitize trade back-office operations, which is why we strategically aligned and invested in a leading fintech, cleareye.ai. Cleareye's automated ClearTrade platform streamlines inefficiencies and resource heavy processes, eliminating the need for your employees to pore over millions of physical documents that litter today's trade finance world.
[00:01:08.36] The ClearTrade platform identifies and extracts information from trade documents and routes it to your back-office system, eliminating rekeying and enhancing operational efficiency. With ClearTrade's Noun Extraction Technology, documents are screened against sanctions. Data is extracted and used to perform automated identification and flagging of trade-based money laundering, dual-use goods, high-risk goods, and vessel and container checks, providing information to help your firm better control and navigate risks associated with each transaction, all while maintaining an audit trail stored in your firm's back-office system.
[00:01:46.91] Cleareye's Auto Doc exam module uses advanced technologies to interpret and identify rules and conditions to optimize banks' trade operations and is highly customizable, providing the control and flexibility to apply rules tailored to banks' needs. We should know. J.P. Morgan Payments brought in Cleareye, and they're helping us run faster and more efficiently. With financial institutions spending upwards of $25 million per year on manual anti-money-laundering compliance and sanctions screening, Cleareye's ClearTrade platform can provide cost savings, alleviate risk, increase transaction volume, open new markets, and so much more.
[00:02:28.11] Put it all together, and it's easy to see why we continue to invest in the global strategic alliance to future-proof our trade business. It's everything your firm needs to take advantage of the changing ways of the industry. Welcome to the future of digital trade. To find out more about our experience using ClearTrade, visit jpmorgan.com/trade, or contact your J.P. Morgan representative.
[00:02:50.31] [MUSIC PLAYING]
[00:02:51.81]
1:17 - Banking
Copa Airlines CFO: Our relationship with J.P. Morgan is "more than transactional"
Jul 20, 2026
Hear how J.P. Morgan connected Copa Airlines CFO Peter Donkersloot to the help his company needed to weather turbulent energy markets and stay focused on long-term priorities.
Markets and Economy
AI use is exploding. So are the bills.
Jul 17, 2026
As artificial intelligence (AI) handles more complex work, usage can outpace budgets. We flag signals to watch – from token price inflation to AI model competition – and the investment implications.
Family Legacy
Insight 4: Initiate interdependent ‘pillars’ separating family and business governance
Jul 17, 2026
Establishing defined groups to organize family activities and learning can be just as valuable as business governance.
Family Legacy
Insight 3: The culture shift from paternalism to partnership
Jul 17, 2026
Developing a new, collaborative culture as leadership shifts from founder to successor is a key attribute of successful generative families.
Family Legacy
8 insights from long-lasting global business families
Jul 17, 2026
The hard work doesn’t end once family economic success is established. These eight insights look at how the next generations can become successful stewards of family wealth.
2:27 - Banking
Data decoded: Aily Labs is building the decision intelligence operating system for the Fortune 500
Jul 16, 2026
Aily Labs is building the decision intelligence operating system for the Fortune 500
Markets and Economy
Biopharma and medtech activity in Q2 2026
Jul 16, 2026
Our Biopharma and Medtech Licensing and Venture Reports examine Q2 2026 venture funding, licensing, M&A and IPO activity.
You're now leaving J.P. Morgan
J.P. Morgan’s website and/or mobile terms, privacy and security policies don’t apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan isn’t responsible for (and doesn’t provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan name.